Zobrazeno 1 - 10
of 272
pro vyhledávání: '"Martin Bland"'
Publikováno v:
BMJ Open, Vol 13, Iss 2 (2023)
Objectives Antiepileptic and antiarrhythmic drugs inhibit voltage-gated sodium (Na+) channels (VGSCs), and preclinical studies show that these medications reduce tumour growth, invasion and metastasis. We investigated the association between VGSC inh
Externí odkaz:
https://doaj.org/article/db9a925477d44a53be4767474335a176
Publikováno v:
Global Epidemiology, Vol 3, Iss , Pp 100045- (2021)
Introduced in 1983, Bland-Altman methods is now considered the standard approach for assessment of agreement between two methods of measurement. The method is widely used by researchers in various disciplines so that the Bland-Altman 1986 Lancet pape
Externí odkaz:
https://doaj.org/article/6caa61a7bf824634a48898b8ce5e07d7
Autor:
Jonathan A. Cook, Steven A. Julious, William Sones, Lisa V. Hampson, Catherine Hewitt, Jesse A. Berlin, Deborah Ashby, Richard Emsley, Dean A. Fergusson, Stephen J. Walters, Edward C. F. Wilson, Graeme Maclennan, Nigel Stallard, Joanne C. Rothwell, Martin Bland, Louise Brown, Craig R. Ramsay, Andrew Cook, David Armstrong, Doug Altman, Luke D. Vale
Publikováno v:
Trials, Vol 19, Iss 1, Pp 1-8 (2018)
Abstract Background A key step in the design of a RCT is the estimation of the number of participants needed in the study. The most common approach is to specify a target difference between the treatments for the primary outcome and then calculate th
Externí odkaz:
https://doaj.org/article/93ca295eced54b009edc65547cf7cb8e
Autor:
William Sones, Steven A. Julious, Joanne C. Rothwell, Craig Robert Ramsay, Lisa V. Hampson, Richard Emsley, Stephen J. Walters, Catherine Hewitt, Martin Bland, Dean A. Fergusson, Jesse A. Berlin, Doug Altman, Luke David Vale, Jonathan Alistair Cook
Publikováno v:
Trials, Vol 19, Iss 1, Pp 1-11 (2018)
Abstract Background A key step in the design of a randomised controlled trial is the estimation of the number of participants needed. The most common approach is to specify a target difference in the primary outcome between the randomised groups and
Externí odkaz:
https://doaj.org/article/786357260d4a4d0fb61b7c490178b14b
Autor:
Junji Yamauchi, Kenichiro Tanabe, Tomoo Sato, Masanori Nakagawa, Eiji Matsuura, Yoshio Tsuboi, Keiko Tamaki, Hirokuni Sakima, Satoshi Ishihara, Yuki Ohta, Naoki Matsumoto, Kenichi Kono, Naoko Yagishita, Natsumi Araya, Katsunori Takahashi, Yasuo Kunitomo, Misako Nagasaka, Ariella Coler-Reilly, Yasuhiro Hasegawa, Abelardo Araujo, Steven Jacobson, Maria Fernanda Rios Grassi, Bernardo Galvão-Castro, Martin Bland, Graham P. Taylor, Fabiola Martin, Yoshihisa Yamano
Publikováno v:
Viruses, Vol 14, Iss 1, p 136 (2022)
Corticosteroids are most commonly used to treat HTLV-1-associated myelopathy (HAM); however, their clinical efficacy has not been tested in randomized clinical trials. This randomized controlled trial included 8 and 30 HAM patients with rapidly and s
Externí odkaz:
https://doaj.org/article/6ef91b8ee069482b9b15bbe412c1b4ee
Autor:
Barry Wright, Helen Phillips, Ann Le Couteur, Jennifer Sweetman, Rachel Hodkinson, Amelia Ralph-Lewis, Emily Hayward, Alice Brennan, Josie Mulloy, Natalie Day, Martin Bland, Victoria Allgar
Publikováno v:
PLoS ONE, Vol 15, Iss 12, p e0243162 (2020)
A Delphi consensus methodology was used to adapt a screening tool, the Social Responsiveness Scale- 2 (SRS-2), for use with deaf children including those whose preferred communication method is sign language. Using this approach; 27 international exp
Externí odkaz:
https://doaj.org/article/05cf1834499140e49ac83787daa59828
Autor:
Jonathan A Cook, Steven A Julious, William Sones, Lisa V Hampson, Catherine Hewitt, Jesse A Berlin, Deborah Ashby, Richard Emsley, Dean A Fergusson, Stephen J Walters, Edward CF Wilson, Graeme MacLennan, Nigel Stallard, Joanne C Rothwell, Martin Bland, Louise Brown, Craig R Ramsay, Andrew Cook, David Armstrong, Douglas Altman, Luke D Vale
Publikováno v:
Health Technology Assessment, Vol 23, Iss 60 (2019)
Background: The randomised controlled trial is widely considered to be the gold standard study for comparing the effectiveness of health interventions. Central to its design is a calculation of the number of participants needed (the sample size) for
Externí odkaz:
https://doaj.org/article/cba0e59595b74186aa0898150edfed89
Autor:
Jonathan A. Cook, Steven A. Julious, William Sones, Joanne C. Rothwell, Craig R. Ramsay, Lisa V. Hampson, Richard Emsley, Stephen J. Walters, Catherine Hewitt, Martin Bland, Dean A. Fergusson, Jesse A. Berlin, Doug Altman, Luke D. Vale
Publikováno v:
Trials, Vol 18, Iss 1, Pp 1-7 (2017)
Abstract Background A key step in the design of a randomised controlled trial (RCT) is the estimation of the number of participants needed. By far the most common approach is to specify a target difference and then estimate the corresponding sample s
Externí odkaz:
https://doaj.org/article/194e122a087d464fa438367cb1911b4b
Autor:
Helen Tilbrook, Laura Clark, Liz Cook, Martin Bland, Hannah Buckley, Ian Chetter, Jo Dumville, Chris Fenner, Rachael Forsythe, Rhian Gabe, Keith Harding, Alison Layton, Ellie Lindsay, Catriona McDaid, Christine Moffatt, Debbie Rolfe, Illary Sbizzera, Gerard Stansby, David Torgerson, Peter Vowden, Laurie Williams, Robert Hinchliffe
Publikováno v:
Health Technology Assessment, Vol 22, Iss 55 (2018)
Background: Venous leg ulcers (VLUs) are the most common cause of leg ulceration, affecting 1 in 100 adults. VLUs may take many months to heal (25% fail to heal). Estimated prevalence is between 1% and 3% of the elderly population. Compression is the
Externí odkaz:
https://doaj.org/article/d6174281675548069e1cf9356c127de3
Autor:
William Sones, Steven A. Julious, Joanne C. Rothwell, Craig Robert Ramsay, Lisa V. Hampson, Richard Emsley, Stephen J. Walters, Catherine Hewitt, Martin Bland, Dean A. Fergusson, Jesse A. Berlin, Doug Altman, Luke David Vale, Jonathan Alistair Cook
Publikováno v:
Trials, Vol 20, Iss 1, Pp 1-1 (2019)
Following publication of the original article [1], we have been notified of a few mistakes:
Externí odkaz:
https://doaj.org/article/69692f15e1094290b0e48810eaf79110